Replies to post #269889 on Avid Bioservices Inc (CDMO)

[Protector]

bfiest, a reverse split is indeed not a forgone for PPHM but it is a possibility. It may all depend on timing, when, what, who, how, how much, how long, etc

So it is better that we are prepared. Again an RS is and MUST be a neutral operation (incluse the authorised shares, outstanding options, PPHMP conversion, etc, etc).

BUT THEN...AFTER a reverse split (if it would happen) an important time starts. If the company keeps bring much and very good numbers (Avid) and new( Bavi pipeline) and new income of Exosomes with a first commercial product, then we will start getting quarterly sales update or licensing income, etc.

The PPS will remain and be supported. If however we end in a dessert of no news or Avid trouble etc then the PPS will not hold IMO and then the RS becomes a bad thing because it created leeway for more down momentum.

The letter to PPHM must at least make sure that the shelf gets split to because otherwise it becomes a source of dilution by shares we didn't authorise in relation to the number of outstanding common stock at the moment of the vote.

[Couch]

Out of this careful analysis, we have settled on a strategy to focus the company's resources primarily on continuing to grow our biomanufacturing business, Avid Bioservices, while continuing to advance R&D efforts through smaller clinical trials and the development of new technologies that can be partnered in an early stage. With the goal of becoming cash flow positive over the next couple of years, this strategy will allow us to increase shareholder value in several ways.

NOW I realize if it were up to me - which clearly it is not - I'd ask management for a shareholder letter laying out BEYOND Avid expansion etc.,......the HOW, WHEN, WHY AND WHERE they PLAN to get BAVI, BBs to MARKET, or FURTHER monetize their new EXOSOME tech???

I find it a touch alarming that at this point a RS is even an option.

Should management wish me to continue to BUY shares......AVID expansion ALONE or the ABOCE is not going to sway me.

The company clearly has potential but come on.